Dennis B. Farrar
Founder at Elute, Inc.
Profile
Mr. Dennis B.
Farrar is an Executive Chairman at Elute, Inc. and a Managing Director at UpStart Ventures LLC.
Mr. Farrar was previously employed as a Co-Founder, President & Chief Executive Officer by Q Therapeutics, Inc., a Chairman by Cognetix, Inc., and a Co-Founder by Myriad Genetics, Inc. He also served on the board at Sera Prognostics, Inc. He received his undergraduate degree from Stanford University and a graduate degree from Stanford Law School.
Dennis B. Farrar active positions
| Companies | Position | Start |
|---|---|---|
Upstart Ventures LLC
 Upstart Ventures LLC Investment ManagersFinance UpStart Ventures LLC (UpStart Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Salt Lake City, Utah. | Private Equity Investor | 2011-01-23 |
Elute, Inc.
 Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Founder | 2009-12-31 |
Former positions of Dennis B. Farrar
| Companies | Position | End |
|---|---|---|
Cognetix, Inc.
 Cognetix, Inc. Drugstore ChainsRetail Trade Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT | Founder | 2010-02-03 |
| MYRIAD GENETICS, INC. | Founder | - |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Founder | - |
| SERA PROGNOSTICS, INC. | Founder | - |
Training of Dennis B. Farrar
| Stanford University | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| SERA PROGNOSTICS, INC. | Health Services |
| Private companies | 4 |
|---|---|
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Cognetix, Inc.
Cognetix, Inc. Drugstore ChainsRetail Trade Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT | Retail Trade |
Upstart Ventures LLC
Upstart Ventures LLC Investment ManagersFinance UpStart Ventures LLC (UpStart Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Salt Lake City, Utah. | Finance |
Elute, Inc.
Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Dennis B. Farrar
